Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Glycadia
- Target Recruit Count
- 54
- Registration Number
- NCT00544921
- Locations
- 🇺🇸
Univ FL, Gainesville, Florida, United States
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Glycadia
- Target Recruit Count
- 42
- Registration Number
- NCT00544934
News
No news found